University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

David A. Larson, M.D.

Radiosurgery specialist

Dr. David A. Larson is an internationally recognized expert on Cyberknife and Gamma Knife brain and body radiosurgery and in intensity modified and conformal radiotherapy for treatment of central nervous system tumors. In addition to treating patients, he lectures extensively and has authored more than 200 scientific papers, reviews and book chapters.

Larson, who is certified by the American Board of Radiology, is past president of the International Stereotactic Radiosurgery Society and American Society for Therapeutic Radiology and Oncology. He has organized many national and international conferences and symposia and serves on the editorial board of numerous medical journals. He earned a doctorate in high-energy physics at the University of Chicago and a medical degree at the University of Miami. After completing an internship at UCSF and a residency at Harvard, he joined the UCSF Medical Center staff. Larson is a professor emeritus in radiation oncology and neurological surgery and continues to treat patients and conduct research at UCSF.

Conditions & Treatments

Clinics

California Center for Pituitary Disorders
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (866) 559-5543

Fax: (415) 353-2939

Hours: Monday to Friday
8 a.m. – 5 p.m.

Neuro-Oncology Clinic
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2966
Fax: (415) 353-2167

Hours: Monday to Friday
8 a.m. – 5 p.m.

Radiation Oncology at Mount Zion
1600 Divisadero St., Basement Level
San Francisco, CA 94143-1708
Phone: (415) 353-9807
Fax: (415) 353-9884

Hours: Monday to Friday
7 a.m. – 6 p.m.

Radiation Oncology at Parnassus
505 Parnassus Ave, Room L-75
San Francisco, CA 94143-0226
Phone: (415) 353-8335
Fax: (415) 353-7281

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

More about David A. Larson

Education

University of Miami 1981

Residencies

Harvard University, Radiation Oncology 1985

Selected Research and Publications

  1. Descovich M, Ma L, Chuang CF, Larson DA, Barani IJ. Comparison between prone and supine patient setup for spine stereotactic body radiosurgery. Technol Cancer Res Treat. 2012 Jun; 11(3):229-36.
  2. Ma L, Sahgal A, Larson D. In Reply to Furweger et al. (Int J Radiat Oncol Biol Phys DOI: 10.1016/j.ijrobp.2009.11.030). Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):1324.
  3. Sahgal A, Ma L, Fowler J, Weinberg V, Gibbs I, Gerszten PC, Ryu S, Soltys S, Chang E, Wong CS, Larson DA. Impact of dose hot spots on spinal cord tolerance following stereotactic body radiotherapy: a generalized biological effective dose analysis. Technol Cancer Res Treat. 2012 Feb; 11(1):35-40.
  4. Sahgal A, Soliman H, Larson DA. Whole-brain radiation therapy of brain metastasis. Prog Neurol Surg. 2012; 25:82-95.
  5. Masucci GL, Yu E, Ma L, Chang EL, Letourneau D, Lo S, Leung E, Chao S, Hyde D, Gorgulho A, Muacevic A, Larson DA, Fehlings MG, Sahgal A. Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practice. Expert Rev Anticancer Ther. 2011 Dec; 11(12):1923-33.
  6. Ma L, Lee L, Barani I, Hwang A, Fogh S, Nakamura J, McDermott M, Sneed P, Larson DA, Sahgal A. Shot sequencing based on biological equivalent dose considerations for multiple isocenter Gamma Knife radiosurgery. Phys Med Biol. 2011 Nov 21; 56(22):7247-56.
  7. Cima RR, Pendlimari R, Holubar SD, Pattana-Arun J, Larson DW, Dozois EJ, Wolff BG, Pemberton JH. Utility and short-term outcomes of hand-assisted laparoscopic colorectal surgery: a single-institution experience in 1103 patients. Dis Colon Rectum. 2011 Sep; 54(9):1076-81.
  8. Ma L, Sahgal A, Hwang A, Hu W, Descovich M, Chuang C, Barani I, Sneed PK, McDermott M, Larson DA. A two-step optimization method for improving multiple brain lesion treatments with robotic radiosurgery. Technol Cancer Res Treat. 2011 Aug; 10(4):331-8.
  9. Larson DL. Definitive diagnosis and management of axillary hyperhidrosis: the VapoMeter and suction-assisted arthroscopic shaving. Aesthet Surg J. 2011 Jul; 31(5):552-9.
  10. Petti PL, Kunwar S, Larson DA. A theoretical investigation of optimal target-dose conformity in gamma knife radiosurgery. Med Phys. 2011 May; 38(5):2812-9.
  11. Larson DB, Meyers ML, O'Hara SM. Reliability of renal length measurements made with ultrasound compared with measurements from helical CT multiplanar reformat images. AJR Am J Roentgenol. 2011 May; 196(5):W592-7.
  12. Larson DB, Johnson LW, Schnell BM, Goske MJ, Salisbury SR, Forman HP. Rising use of CT in child visits to the emergency department in the United States, 1995-2008. Radiology. 2011 Jun; 259(3):793-801.
  13. Ma L, Petti P, Wang B, Descovich M, Chuang C, Barani IJ, Kunwar S, Shrieve DC, Sahgal A, Larson DA. Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple brain metastases. J Neurosurg. 2011 Jun; 114(6):1580-4.
  14. Sahgal A, Bilsky M, Chang EL, Ma L, Yamada Y, Rhines LD, Létourneau D, Foote M, Yu E, Larson DA, Fehlings MG. Stereotactic body radiotherapy for spinal metastases: current status, with a focus on its application in the postoperative patient. J Neurosurg Spine. 2011 Feb; 14(2):151-66.
  15. Ma L, Sahgal A, Cozzi L, Chang E, Shiu A, Letourneau D, Yin FF, Fogliata A, Kaissl W, Hyde D, Laperriere NJ, Shrieve DC, Larson DA. Apparatus-dependent dosimetric differences in spine stereotactic body radiotherapy. Technol Cancer Res Treat. 2010 Dec; 9(6):563-74.
  16. Holubar SD, Dozois EJ, Loftus EV, Teh SH, Benavente LA, Harmsen WS, Wolff BG, Cima RR, Larson DW. Primary intestinal lymphoma in patients with inflammatory bowel disease: a descriptive series from the prebiologic therapy era. Inflamm Bowel Dis. 2011 Jul; 17(7):1557-63.
  17. Sahgal A, Ma L, Weinberg V, Gibbs IC, Chao S, Chang UK, Werner-Wasik M, Angelov L, Chang EL, Sohn MJ, Soltys SG, Létourneau D, Ryu S, Gerszten PC, Fowler J, Wong CS, Larson DA. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):107-16.
  18. Sahgal A, Barani IJ, Novotny J, Zhang B, Petti P, Larson DA, Ma L. Prescription dose guideline based on physical criterion for multiple metastatic brain tumors treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2010 Oct 1; 78(2):605-8.
  19. Ma L, Sahgal A, Descovich M, Cho YB, Chuang C, Huang K, Laperriere NJ, Shrieve DC, Larson DA. Equivalence in dose fall-off for isocentric and nonisocentric intracranial treatment modalities and its impact on dose fractionation schemes. Int J Radiat Oncol Biol Phys. 2010 Mar 1; 76(3):943-8.
  20. Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010 Feb 1; 76(2):326-32.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.